The inhibitor of COX-2, such as 5-ASA and aspirin both successfully supported in chemoprevention, has been proven to be a key point to alleviate colonic inflammation even with CRC occurrence (Burn et al., 2011; Kaur et al., 2020). Here, PTGS2 is linked to colorectal carcinoma.